179 related articles for article (PubMed ID: 26182876)
21. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
Szebeni J; Alving CR; Rosivall L; Bünger R; Baranyi L; Bedöcs P; Tóth M; Barenholz Y
J Liposome Res; 2007; 17(2):107-17. PubMed ID: 17613700
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model.
Szebeni J
Methods Mol Biol; 2024; 2789():229-243. PubMed ID: 38507008
[TBL] [Abstract][Full Text] [Related]
23. Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function.
Szebeni J; Baranyi L; Sávay S; Bodó M; Milosevits J; Alving CR; Bünger R
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1050-8. PubMed ID: 16214844
[TBL] [Abstract][Full Text] [Related]
24. Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo.
Buscema M; Matviykiv S; Mészáros T; Gerganova G; Weinberger A; Mettal U; Mueller D; Neuhaus F; Stalder E; Ishikawa T; Urbanics R; Saxer T; Pfohl T; Szebeni J; Zumbuehl A; Müller B
J Control Release; 2017 Oct; 264():14-23. PubMed ID: 28803115
[TBL] [Abstract][Full Text] [Related]
25. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
Kozma GT; Mészáros T; Vashegyi I; Fülöp T; Örfi E; Dézsi L; Rosivall L; Bavli Y; Urbanics R; Mollnes TE; Barenholz Y; Szebeni J
ACS Nano; 2019 Aug; 13(8):9315-9324. PubMed ID: 31348638
[TBL] [Abstract][Full Text] [Related]
26. Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs.
Bavli Y; Winkler I; Chen BM; Roffler S; Cohen R; Szebeni J; Barenholz Y
J Control Release; 2019 Jul; 306():138-148. PubMed ID: 31176656
[TBL] [Abstract][Full Text] [Related]
27. A porcine model of hemodialyzer reactions: roles of complement activation and rinsing back of extracorporeal blood.
Pethő Á; Piecha D; Mészáros T; Urbanics R; Moore C; Canaud B; Rosivall L; Mollnes TE; Steppan S; Szénási G; Szebeni J; Dézsi L
Ren Fail; 2021 Dec; 43(1):1609-1620. PubMed ID: 34882053
[TBL] [Abstract][Full Text] [Related]
28. Application of KU812 cells for assessing complement activation related effects by nano(bio)materials.
David CAW; de la Fonteyne-Blankestijn LJJ; Vermeulen JP; Plant-Hately AJ; Vandebriel RJ; Liptrott NJ
Biomed Pharmacother; 2023 Jul; 163():114841. PubMed ID: 37167727
[TBL] [Abstract][Full Text] [Related]
29. Surprising lack of liposome-induced complement activation by artificial 1,3-diamidophospholipids in vitro.
Bugna S; Buscema M; Matviykiv S; Urbanics R; Weinberger A; Meszaros T; Szebeni J; Zumbuehl A; Saxer T; Müller B
Nanomedicine; 2016 Apr; 12(3):845-849. PubMed ID: 26733261
[TBL] [Abstract][Full Text] [Related]
30. Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
Dézsi L; Mészáros T; Őrfi E; Fülöp TG; Hennies M; Rosivall L; Hamar P; Szebeni J; Szénási G
Molecules; 2019 Sep; 24(18):. PubMed ID: 31505853
[TBL] [Abstract][Full Text] [Related]
31. Liposome-induced hypersensitivity reactions: Risk reduction by design of safe infusion protocols in pigs.
Fülöp T; Kozma GT; Vashegyi I; Mészáros T; Rosivall L; Urbanics R; Storm G; Metselaar JM; Szebeni J
J Control Release; 2019 Sep; 309():333-338. PubMed ID: 31295544
[TBL] [Abstract][Full Text] [Related]
32. A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.
Dézsi L; Mészáros T; Kozma G; H-Velkei M; Oláh CZ; Szabó M; Patkó Z; Fülöp T; Hennies M; Szebeni M; Barta BA; Merkely B; Radovits T; Szebeni J
Geroscience; 2022 Apr; 44(2):597-618. PubMed ID: 35146583
[TBL] [Abstract][Full Text] [Related]
33. Drug-Induced Pseudoallergy: A Review of the Causes and Mechanisms.
Zhang B; Li Q; Shi C; Zhang X
Pharmacology; 2018; 101(1-2):104-110. PubMed ID: 29136631
[TBL] [Abstract][Full Text] [Related]
34. Complement activation by PEGylated liposomes containing prednisolone.
van den Hoven JM; Nemes R; Metselaar JM; Nuijen B; Beijnen JH; Storm G; Szebeni J
Eur J Pharm Sci; 2013 May; 49(2):265-71. PubMed ID: 23528740
[TBL] [Abstract][Full Text] [Related]
35. PEGylated liposomes: immunological responses.
Mohamed M; Abu Lila AS; Shimizu T; Alaaeldin E; Hussein A; Sarhan HA; Szebeni J; Ishida T
Sci Technol Adv Mater; 2019; 20(1):710-724. PubMed ID: 31275462
[TBL] [Abstract][Full Text] [Related]
36. Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron.
Macdougall IC; Vernon K
Am J Nephrol; 2017; 45(1):60-62. PubMed ID: 27894115
[No Abstract] [Full Text] [Related]
37. Interchangeability of Generics-Experiences and Outlook Toward Pharmacokinetics Variability and Generic-Generic Substitution.
Yu Y; Maliepaard M
Clin Pharmacol Ther; 2019 Feb; 105(2):292-294. PubMed ID: 30460681
[No Abstract] [Full Text] [Related]
38. In vivo applications of PEG liposomes: unexpected observations.
Laverman P; Boerman OC; Oyen WJG ; Corstens FHM ; Storm G
Crit Rev Ther Drug Carrier Syst; 2001; 18(6):551-66. PubMed ID: 11789675
[TBL] [Abstract][Full Text] [Related]
39. Hypersensitivity reactions to intravenous lipid emulsion in swine: relevance for lipid resuscitation studies.
Bedocs P; Capacchione J; Potts L; Chugani R; Weiszhar Z; Szebeni J; Buckenmaier CC
Anesth Analg; 2014 Nov; 119(5):1094-101. PubMed ID: 25126705
[TBL] [Abstract][Full Text] [Related]
40. Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.
Moghimi SM; Hamad I; Andresen TL; Jørgensen K; Szebeni J
FASEB J; 2006 Dec; 20(14):2591-3. PubMed ID: 17065229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
